Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Clinical trial NCT00135876 · COMPLETED
Trial details
- NCT number
- NCT00135876
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.